Animal Rights

In his call to arms against the animal rights movement (The Scientist, Nov. 23, 1992, page 12), Patrick Cleveland attempts to demonize the Humane Society of the United States (HSUS) by lumping it with organizations and individuals that oppose all animal research, condone terrorism, and vilify scientists. As the person in charge of HSUS's programs on animal research issues, I would like to respond to this blatant mischaracterization. HSUS does not oppose all animal research. Our policy advocate

Written byMartin Stephens
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

In his call to arms against the animal rights movement (The Scientist, Nov. 23, 1992, page 12), Patrick Cleveland attempts to demonize the Humane Society of the United States (HSUS) by lumping it with organizations and individuals that oppose all animal research, condone terrorism, and vilify scientists. As the person in charge of HSUS's programs on animal research issues, I would like to respond to this blatant mischaracterization.

HSUS does not oppose all animal research. Our policy advocates reform, not abolition. Our programs are pragmatic attempts to reduce the suffering and use of laboratory animals without compromising biomedical science. Our work is guided by our Scientific Advisory Council, which consists of physicians, scientists, and veterinarians from prominent institutions.

HSUS has been very clear on our opposition to terrorism and violence. We have expressed our views before Congress, in full- page ads in the New York Times, and here.

HSUS has ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies